Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential Tremor
Consistent use of TAPS was associated with significant improvement in underlying tremor severity in patients with essential tremor. These findings suggest that regular TAPS use may confer sustained therapeutic benefit.
Authors
- Mark Lew
- H. A. Shill
- Fernando Pagán (ORCID: https://orcid.org/0000-0002-4052-156X)
- Melita Petrossian (ORCID: https://orcid.org/0000-0002-3948-9638)
- Pravin Khemani (ORCID: https://orcid.org/0000-0003-3579-9230)
- Ejaz A. Shamim
- Lan Luo
- Kathryn H. Rosenbluth
- Nijee Luthra
- Jessica Tate
- Chiahao Lu
- Elizabeth Peckham
- John Morgan
- Winona Tse
- William Ondo
- Scott L. Delp
- Rajesh Pahwa
- Michael J. Soileau
- Mark Hallett
- Stuart H. Isaacson
- Cameron Dietiker
Institutions
- Houston Methodist (US)
- Beth Israel Deaconess Medical Center (US)
- Barrow Neurological Institute (US)
- Kaiser Permanente (US)
- Harvard University (US)
- University of Arizona (US)
- Palo Alto University (US)
- University of California, San Francisco (US)
- Georgetown University (US)
- Cornell University (US)
- Augusta University (US)
- Keck Hospital of USC (US)
- Central Texas Neurology Consultants (US)
- Swedish Medical Center (US)
- National Institute of Neurological Disorders and Stroke (US)
- Parkinson's Research and Education Foundation (US)
- University of Kansas Medical Center (US)
- Pacific Heart Institute (US)
- Evergreen Health Medical Center (US)
- Wake Forest University (US)
- University of Arkansas for Medical Sciences (US)
- Stanford University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Tremor and Other Hyperkinetic Movements
- Published
- 2026-01-01
- DOI
- https://doi.org/10.5334/tohm.1091
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gordon and Betty Moore Foundation
- Alzheimer's Drug Discovery Foundation
- Eli Lilly and Company
- Biogen
- CHDI Foundation
- Teva Pharmaceutical Industries
- International Parkinson and Movement Disorder Society
- Boston Scientific Corporation
- Sunovion
- Kinetics Foundation
- Parkinson's Foundation
- ACADIA Pharmaceuticals
- Acorda Therapeutics
- Neurocrine Biosciences
- BrainsWay
- Mitsubishi Tanabe Pharma Corporation
- H. Lundbeck A/S
- Sun Pharma
- National Institutes of Health
- Genentech
- Allergan
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- National Institute of Environmental Health Sciences